Clinical Trial Update: REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy [NA]

View source ↗

Summary

A clinical trial update for REFINE-HCM evaluating intramyocardial septal radiofrequency ablation to treat obstructive hypertrophic cardiomyopathy. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: SuZhou Sinus Medical Technologies Co.,Ltd | Conditions: Hypertrophic Cardiomyopathy, Obstructive | NA | Status: RECRUITING